Service de Pneumologie, Faculté de Médecine, Université de Sherbrooke, Sherbrooke, Québec J1H 5N4, Canada;
J Immunol. 2013 Oct 15;191(8):4299-307. doi: 10.4049/jimmunol.1301117. Epub 2013 Sep 13.
Neutrophils influence innate and adaptative immunity by generating numerous cytokines and chemokines whose regulation largely depends on transcriptional activators such as NF-κB and C/EBP factors. In this study, we describe the critical involvement of CREB transcription factors (CREB1 and activating transcription factor-1) in this functional response as well as relevant upstream signaling components. Neutrophil stimulation with LPS or TNF led to the phosphorylation, DNA binding activity, and chemokine promoter association of CREB1 and activating transcription factor-1. These responses occurred downstream of the p38-MSK1 signaling axis, as did the phosphorylation and promoter association of another bZIP factor, C/EBPβ. Conversely, inhibition of RSK1 failed to alter the phosphorylation of either CREB1 or C/EBPβ in neutrophils. From a more functional standpoint, the inhibition of p38 MAPK or MSK1 interfered with cytokine generation in neutrophils. Likewise, overexpression of a dominant-negative CREB1 mutant (K-CREB) or of a point mutant (S133A) resulted in a decreased ability of human neutrophil-like PLB-985 cells to generate inflammatory cytokines (CXCL8, CCL3, CCL4, and TNF-α). Collectively, our data show the involvement of CREB1 in neutrophil cytokine production, the key role of its S133 residue, important upstream signaling events, and the parallel activation of another bZIP factor. These are all potential molecular targets that could be exploited in the context of several chronic inflammatory diseases that prominently feature neutrophils and their products.
中性粒细胞通过生成大量细胞因子和趋化因子来影响先天免疫和适应性免疫,这些细胞因子和趋化因子的调节在很大程度上依赖于转录激活因子,如 NF-κB 和 C/EBP 因子。在这项研究中,我们描述了 CREB 转录因子(CREB1 和激活转录因子-1)在这种功能反应以及相关上游信号成分中的关键作用。用 LPS 或 TNF 刺激中性粒细胞会导致 CREB1 和激活转录因子-1 的磷酸化、DNA 结合活性和趋化因子启动子结合。这些反应发生在 p38-MSK1 信号轴的下游,另一个 bZIP 因子 C/EBPβ的磷酸化和启动子结合也是如此。相反,抑制 RSK1 并不能改变中性粒细胞中 CREB1 或 C/EBPβ的磷酸化。从更具功能性的角度来看,抑制 p38 MAPK 或 MSK1 会干扰中性粒细胞中细胞因子的生成。同样,过表达显性失活的 CREB1 突变体(K-CREB)或点突变体(S133A)会导致人中性粒细胞样 PLB-985 细胞生成炎症细胞因子(CXCL8、CCL3、CCL4 和 TNF-α)的能力下降。总之,我们的数据表明 CREB1 参与中性粒细胞细胞因子的产生,其 S133 残基的关键作用,重要的上游信号事件以及另一个 bZIP 因子的平行激活。这些都是可能的分子靶点,可以在几种以中性粒细胞及其产物为特征的慢性炎症性疾病中得到利用。